0001209191-23-010915.txt : 20230217
0001209191-23-010915.hdr.sgml : 20230217
20230217191307
ACCESSION NUMBER: 0001209191-23-010915
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bekiroglu Elizabeth
CENTRAL INDEX KEY: 0001884087
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40655
FILM NUMBER: 23644718
MAIL ADDRESS:
STREET 1: 1616 EASTLAKE AVENUE E
STREET 2: SUITE 208
CITY: SEATTLE
STATE: WA
ZIP: 98102-3793
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Icosavax, Inc.
CENTRAL INDEX KEY: 0001786255
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1930 BOREN AVE., SUITE 1000
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: (206) 737-0085
MAIL ADDRESS:
STREET 1: 1930 BOREN AVE., SUITE 1000
CITY: SEATTLE
STATE: WA
ZIP: 98101
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-15
0
0001786255
Icosavax, Inc.
ICVX
0001884087
Bekiroglu Elizabeth
C/O ICOSAVAX, INC.
1930 BOREN AVE., SUITE 1000
SEATTLE
WA
98101
0
1
0
0
General Counsel & Corp. Sec.
Stock Option (Right to Buy)
9.06
2023-02-15
4
A
0
100000
0.00
A
2033-02-14
Common Stock
100000
100000
D
25% of the shares subject to the option will vest on February 15, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date.
/s/ Elizabeth Bekiroglu
2023-02-17